Key result
Higher blood omega-3 levels linked to lower RDW and 5-year mortality post-MI.
Why the study?
Omega-3 fatty acids are inversely related to red cell distribution width in the general population, but their associations with red cell distribution width and prognosis had not been studied in post-myocardial infarction patients.
Are higher levels of dietary or blood omega-3 fatty acids associated with lower red cell distribution width and improved mortality in patients with prior myocardial infarction?
Are higher levels of dietary or blood omega-3 fatty acids associated with lower red cell distribution width and improved mortality in patients with prior myocardial infarction?
Higher dietary and blood levels of omega-3 fatty acids are associated with lower RDW and improved mortality after myocardial infarction, with RDW partially mediating this protective effect.
May inform post-MI risk stratification via omega-3 and RDW; leaves open causal confirmation in randomized trials.
Background A high red cell distribution width (RDW) reflects an inflammatory state and abnormal red blood cell function, which has been associated with poor prognosis in patients with prior myocardial infarction (MI). Omega-3 fatty acids (n-3 FAs) are inversely related to RDW in the general population but have not been studied in post-MI patients. We aimed to explore associations between n-3 FAs, RDW and prognosis in individuals with prior MI by analyzing electronic health records (EHRs). Methods This study analyzed two cohorts from the National Health and Nutrition Examination Survey (NHANES) and the UK Biobank databases. In the NHANES cohort, associations between dietary n-3 FA intake, RDW, and mortality were explored using multivariable Cox proportional hazards regression and restricted cubic splines (RCSs). In the UK Biobank cohort, associations between n-3 blood biomarkers, RDW, and 5 year mortality were examined through Spearman correlations, multivariate Cox proportional hazards regression, RCSs, and Karlson–Holm–Breen (KHB) mediation analysis. Finally, in the internal dataset, this study explored the potential role of RDW in the association between plasma eicosapentaenoic acid (EPA) level and the 6 month major adverse cardiovascular events (MACE) incidence using KHB mediation analysis. Results RDW was positively associated with mortality in both cohorts from public databases. Dietary n-3 FA intake were inversely associated with RDW. Blood n-3 biomarkers were significantly inversely associated with RDW and 5 year mortality. Moreover, RDW appears to partially mediate the relationship between n-3 blood biomarkers and 5 year mortality. The internal dataset also suggested that RDW may modestly influence the association between plasma EPA level and 6-month MACE incidence. Conclusions Both dietary and blood levels of n-3 FAs are negatively associated with RDW in individuals with prior MI. The findings are consistent with the hypothesis that RDW may play a potential mediating role in the association between n-3 FAs and mortality risk. Given that a high RDW signifies an inflammatory state and abnormal erythrocyte function, the observed association between higher blood levels of n-3 FAs and improved prognosis after MI aligns with potential underlying mechanisms: attenuated inflammation and enhanced erythrocyte function.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question. Higher blood levels of omega-3 fatty acids were inversely associated with red cell distribution width and 5-year mortality in patients post-myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: